4-(4-((叔丁氧基羰基)氨基)-1-甲基-1H-吡咯-2-甲酰胺基)-1-甲基-1H-咪唑-2-羧酸 | 180258-47-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 4-(4-((叔丁氧基羰基)氨基)-1-甲基-1H-吡咯-2-甲酰胺基)-1-甲基-1H-咪唑-2-羧酸
• 英文名称: 4-(4-(tert-butoxycarbonylamino)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid
• 英文别名: 4-(4-((tert-Butoxycarbonyl)amino)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid；1-methyl-4-[[1-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrole-2-carbonyl]amino]imidazole-2-carboxylic acid
• CAS: 180258-47-3
• 化学式: C₁₆H₂₁N₅O₅
• 分子量: 363.373
• InChiKey: QEAAGUOJJNLEJC-UHFFFAOYSA-N

物化性质

• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  128
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-(4-((叔丁氧基羰基)氨基)-1-甲基-1H-吡咯-2-甲酰胺基)-1-甲基-1H-咪唑-2-羧酸 在 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 C₁₈H₂₁N₇O₄
  参考文献：
  名称：

  WO2022/150555

  摘要：

  公开号：
• 作为产物：
  描述：

  1-甲基-1H-咪唑-2-甲酸乙酯 在 palladium on activated charcoal sodium hydroxide 、 硫酸 、 氢气 、 硝酸 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 乙醇 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 60.0 ℃ 、111.46 kPa 条件下， 反应 48.83h， 生成 4-(4-((叔丁氧基羰基)氨基)-1-甲基-1H-吡咯-2-甲酰胺基)-1-甲基-1H-咪唑-2-羧酸
  参考文献：
  名称：

  Solid Phase Synthesis of Polyamides Containing Imidazole and Pyrrole Amino Acids

  摘要：

  The solid phase synthesis of sequence specific DNA binding polyamides containing N-methylimidazole (Im) and N-methylpyrrole (Py) amino acids is described. Two monomer building blocks, Boc-Py-OBt ester and Boc-Im acid, are prepared on a 50 g scale without column chromatography. Using commercially available Boc-beta-alanine-Pam resin, cycling protocols were optimized to afford high stepwise coupling yields (>99%). Deprotection by aminolysis affords up to 100 mg quantities of polyamide. Solid phase methodology increases both the number and complexity of minor groove binding polyamides which can be synthesized and analyzed with regard to DNA binding affinity and sequence specificity. The solid phase synthesis of a representative eight-residue polyamide is reported.

  DOI：

  10.1021/ja960720z

文献信息

• [EN] NOVEL BENZODIAZEPINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE BENZODIAZÉPINE
  申请人：IMMUNOGEN INC

  公开号：WO2010091150A1

  公开（公告）日：2010-08-12

  The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  该发明涉及具有抗增殖活性的新型苯二氮䓬啶衍生物，更具体地涉及具有式(I)和(II)的新型苯二氮䓬啶化合物，其中二氮䓬啶环(B)与杂环环(CD)融合，其中杂环环是双环的或式(III)的化合物，其中二氮䓬啶环(B)与杂环环(C)融合，其中杂环环是单环的。该发明提供了这些化合物的细胞毒性二聚体。该发明还提供了单体和二聚体的结合物。该发明进一步提供了使用该发明的化合物或结合物抑制异常细胞生长或治疗哺乳动物增殖性疾病的有效组合物和方法。该发明还涉及使用该发明的化合物或结合物进行体外、原位和体内诊断或治疗哺乳动物细胞或相关病理条件的方法。
• [EN] C8, C8' LINKED 5-OXO-1,2,3,11A-TETRAHYDRO-5H-PYRROLO[2,1-C][1,4]BENZODIAZEPINE DIMERS WITH 1H-PYRROLE-DICARBOXYLIC ACID AMIDE LINKERS AND OLIGOMERIC ANALOGS THEROF AS WELL AS RELATED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISEASES<br/>[FR] DIMERES DE C8,C8' 5-OXO-1,2,3, 11A-TETRAHYDRO-5H-PYRROLO[2,1-C][1,4]BENZODIAZEPINE LIES PAR DES LIEURS D'AMIDE D'ACIDE 1-H-PYRROLE-DICARBOXYLIQUE ET LEURS ANALOGUES OLIGOMERES AINSI QUE DES COMPOSES CONNEXES DESTINES AU TRAITEMENT DE MALADIES PROLIFERATIVES
  申请人：SPIROGEN LTD

  公开号：WO2005085250A1

  公开（公告）日：2005-09-15

  Compounds of formula (I): PBD-A-Y-X- (Het)na-L- (Het)nb-L- (Het)nc-T- (Het')nd-L- (Het')ne-L- (Het')nf-X' -Y' -A' -PBD' and salts, solvates and chemically protected forms thereof, are disclosed wherein the PBD units have the formulae (PBD) (PBD') with the bonds at the 8 position on each molecule bond to the A and A' groups respectively ; A is selected from O, S, NH or a single bond , and each Het and Het' is respectively an amino-heteroarylene-carbonyl group ; X and X' are both either NH or C (=O) -Q-C (=O) - wherein Q is a divalent group such that HY = R ; in a second aspectm the invention comprises compounds of the general formula (II) : PBD-A-Y-X-(Het)ng-[L-(Het)nh] nj-X' -Y' -A' -PBD'. Wherein : PBD and PBD' are as defined above, X and X' are either NH and C(=O) respectively or C(O) and NH respectively ; the other substituents are defined in the claims. Further aspects of the present invention relate to their use in the manufacture of a medicament for the treatment of a proliferative disease.

  公式（I）的化合物：PBD-A-Y-X-（Het）na-L-（Het）nb-L-（Het）nc-T-（Het'）nd-L-（Het'）ne-L-（Het'）nf-X'-Y'-A'-PBD'及其盐、溶剂合物和化学保护形式，其中PBD单位具有化学式（PBD）（PBD'），每个分子的8位置的键分别与A和A'基团结合；A从O、S、NH或单键中选择，每个Het和Het'分别为氨基-杂芳基-羰基基团；X和X'都是NH或C（=O）-Q-C（=O）-，其中Q是二价基团，使得HY = R；在第二方面，本发明涉及一般化学式（II）的化合物：PBD-A-Y-X-(Het)ng-[L-(Het)nh] nj-X'-Y'-A'-PBD'。其中：PBD和PBD'如上所定义，X和X'分别为NH和C（=O）或C（O）和NH；其他取代基在权利要求中定义。本发明的其他方面涉及它们在制造用于治疗增殖性疾病的药物中的用途。
• Parallel Synthesis and Evaluation of 132 (+)-1,2,9,9a-Tetrahydrocyclopropa[<i>c</i>]benz[<i>e</i>]indol-4-one (CBI) Analogues of CC-1065 and the Duocarmycins Defining the Contribution of the DNA-Binding Domain
  作者：Dale L. Boger、Harald W. Schmitt、Brian E. Fink、Michael P. Hedrick

  DOI：10.1021/jo010454u

  日期：2001.10.1

  9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins containing dimeric monocyclic, bicyclic, and tricyclic heteroaromatic replacements for the DNA-binding domain are described. This systematic study revealed clear trends in the structural requirements for observation of potent cytotoxic activity and DNA alkylation efficiency, the range of which spans a magnitude of >

  CC-1065和Duocarmycins的132（+）-1,2,9,9a-四氢环丙烷[c]苯并[e]吲哚-4-酮（CBI）类似物的文库的溶液相平行合成和评价描述了含有DNA结合域的二聚单环，双环和三环杂芳族取代基。这项系统的研究揭示了用于观察有效细胞毒性活性和DNA烷基化效率的结构要求的明显趋势，其范围跨越>或= 10000倍。与相关研究相结合，这些结果表明，DNA结合结构域的作用不仅限于提供DNA结合的选择性和亲和力（性能提高10到100倍），
• NOVEL BENZODIAZEPINE DERIVATIVES
  申请人：Li Wei

  公开号：US20100203007A1

  公开（公告）日：2010-08-12

  The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  本发明涉及具有抗增殖活性的新型苯二氮平衍生物，更具体地涉及公式（I）和（II）的新型苯二氮平，其中二氮平环（B）与杂环环（CD）融合，其中杂环环为双环或公式（III）的化合物，其中二氮平环（B）与杂环环（C）融合，其中杂环环为单环。本发明提供这些化合物的细胞毒性二聚体。本发明还提供单体和二聚体的结合物。本发明还提供使用该发明的化合物或结合物抑制异常细胞生长或治疗哺乳动物增殖性疾病的组合物和方法。本发明还涉及使用该化合物或结合物进行哺乳动物细胞的体外、原位和体内诊断或治疗，或相关病理条件的方法。
• Benzodiazepine derivatives
  申请人：Li Wei

  公开号：US08809320B2

  公开（公告）日：2014-08-19

  The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  本发明涉及具有抗增殖活性的新型苯二氮平衍生物，更具体地涉及公式（I）和（II）的新型苯二氮平，其中二氮平环（B）与杂环环（CD）融合，其中杂环环为双环或公式（III）的化合物，其中二氮平环（B）与杂环环（C）融合，其中杂环环为单环。本发明提供了这些化合物的细胞毒性二聚体。本发明还提供了单体和二聚体的结合物。本发明还提供了使用本发明的化合物或结合物用于抑制异常细胞生长或治疗哺乳动物增殖性疾病的组合物和方法。本发明还涉及使用本发明的化合物或结合物进行哺乳动物细胞的体外、原位和体内诊断或治疗，或相关病理条件的方法。